Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Viridian Therapeutics, Inc.\DE | fy202010kex321.htm |
| EX-31.2 - EX-31.2 - Viridian Therapeutics, Inc.\DE | fy202010kex312.htm |
| EX-31.1 - EX-31.1 - Viridian Therapeutics, Inc.\DE | fy202010kex311.htm |
| EX-23.1 - EX-23.1 - Viridian Therapeutics, Inc.\DE | fy202010kex231.htm |
| EX-10.23 - EX-10.23 - Viridian Therapeutics, Inc.\DE | fy202010kex1023.htm |
| EX-10.18 - EX-10.18 - Viridian Therapeutics, Inc.\DE | fy202010kex1018.htm |
| EX-10.17 - EX-10.17 - Viridian Therapeutics, Inc.\DE | fy202010kex1017.htm |
| EX-10.14 - EX-10.14 - Viridian Therapeutics, Inc.\DE | fy202010kex1014.htm |
| EX-10.3 - EX-10.3 - Viridian Therapeutics, Inc.\DE | fy202010kex103.htm |
| EX-10.2 - EX-10.2 - Viridian Therapeutics, Inc.\DE | fy202010kex102.htm |
| EX-4.5 - EX-4.5 - Viridian Therapeutics, Inc.\DE | fy202010kex45.htm |
| 10-K - 10-K - Viridian Therapeutics, Inc.\DE | mgen-20201231.htm |
Exhibit 21.1
Subsidiaries of the Registrant
(as of March 26, 2021)
| Name of Subsidiary | Jurisdiction of Incorporation | ||||
| Viridian Therapeutics Europe Limited | England and Wales | ||||
| Viridian Therapeutics S.á.r.l. | Luxembourg | ||||